Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508376 | SCV001714497 | uncertain significance | not provided | 2020-05-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001508376 | SCV003512745 | uncertain significance | not provided | 2022-05-30 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 425 of the CDAN1 protein (p.Pro425Ala). This variant is present in population databases (rs191247450, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with CDAN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1163374). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV003145679 | SCV003829414 | uncertain significance | Anemia, congenital dyserythropoietic, type 1a | 2021-11-12 | criteria provided, single submitter | clinical testing |